Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
2006-05-23
2010-06-29
Bristol, Lynn (Department: 1643)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
Reexamination Certificate
active
07745121
ABSTRACT:
The present invention relates to the risk assessment, detection, diagnosis, or prognosis of prostate cancer. More specifically, this invention relates to the detection of certain polymorphism in the promoter region of the MIF gene to determine the risk, detect, diagnose, or prognosticate prostate cancer. Applicants have discovered that the presence of a −173C and/or −749 (CATT)7 or morerepeat predispose an individual to prostate cancer.
REFERENCES:
patent: 6287772 (2001-09-01), Stefano et al.
patent: 6468742 (2002-10-01), Nerenberg et al.
patent: 6821727 (2004-11-01), Livak et al.
patent: 6902900 (2005-06-01), Davies et al.
patent: 6905829 (2005-06-01), Cho et al.
patent: 7205107 (2007-04-01), Baugh et al.
patent: 7361474 (2008-04-01), Siegler
patent: 2001/0046670 (2001-11-01), Brookes
patent: WO-00/20633 (2000-04-01), None
Meyer-Siegler et al. (Cancer 94:1449-1456 (2002).
Hutchinson's on-line dictionary definition for “chemiluminescence”.
Donn et al. Arthritis Rheum. 44:1782-1785 (2001).
Donn et al. Arthritis Rheum. 46:2402-2409 (2002).
Baugh et al. Genes & Immunity 3:170-176 (2002).
Gerwirtz et al. (Blood 92(3): 712-736, 1998).
Opalinska et al. (Nature Reviews 1:503-514, 2002).
Ding et al. (J. Surgical Oncol. 100:106-110 (2009)).
Li Gao et al. “Macrophage Migration Inhibitory Factor in Acute Lung Injury: Expression, Biomarker and Associations”. Transl Res. 2007; 150(1): 18-29.
B. J. Plant et al. “Sarcoidosis and MIF gene polymorphism: a case-control study in an Irish population”. Eur Respir J 2007; 29: 325-329.
Bianca Miterski et al. “Complex genetic predisposition in adult and juvenile rheumatoid arthritis”. BMC Genetics 2004, 5:2, Feb. 4, 2004.
M. M. Amoli et al. “Lack of association between macrophage migration inhibitory factor gene (-173 G/C) polymorphism and cutaneous vasculitis”. Clinical and Experimental Rheumatology 2006, pp. 576-579.
Timothy R. D. J. Radstake et al. “Correlation of Rheumatoid Arthritis Severity With the Genetic Functional Variants and Circulating Levels of Macrophage Inhibitory Factor”. Arthritis & Rheumatism, vol. 52, No. 10, Oct. 2005, pp. 3020-3029.
Julia Dambacher et al. “Macrophage Migration Inhibitory Factor (MIF)—173G/C Promoter Polymorphism Influences Upper Gastrointestinal Tract Involvement and Disease Activity in Patients with Crohn's Disease.” Inflamm Bowel Dis, vol. 13, No. 1, Jan. 2007, pp. 71-82.
Sou-Pan Wu et al. “Macrophage Migration . . . ”. Arthritis and Rheumatism 54: 3661-3669, 2006.
Bucala Richard
Iczkowski Kenneth
Siegler Katherine
Vera Pedro L.
Blank Rome LLP
Bristol Lynn
The Department of Veterans Affairs
LandOfFree
Polymorphism in the macrophage migration inhibitory factor... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Polymorphism in the macrophage migration inhibitory factor..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Polymorphism in the macrophage migration inhibitory factor... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4195685